GSM9324258: sIL-2 TILs, scRNA-seq; Mus musculus; RNA-Seq
For the low dose regimen of sIL-2, sIL-2 + IL-21, or IL-2/21-treatment in the B16F10 +pmel ACT model, tumors from mice were harvested on day 18 following tumor injection. Tumorswere minced and dissociated using a gentleMACS Octo Dissociator. TILs were collected forsequencing by sorting for live, single cell, Thy1.1+CD8+ cells on a Sony Cell Sorter SH800S. 10x 3' Gene Expression v3.1
GEO
GSM9324258_r1